Jabra Enhance Select 50R vs Resound Vivia 9 60S microRIE

The Jabra Enhance Select 50R is a premium-priced OTC hearing aid at $1,195, earning a B grade with a SoundScore of 3.7/5 in our lab testing. This behind-the-ear device ranks #29 of 65 OTC hearing aids tested, placing it in the top 43% of its category. In our testing, the Select 50R demonstrates notable strengths in speech clarity during quiet environments, scoring 3.5/5—a solid result that sits 0.75 points above the category average. Feedback handling is excellent at 5.0/5, meaning users can expect stable performance without whistling during typical wear. Music streaming also performs above average at 2.8/5, though this remains mixed in absolute terms. The device shows limitations in challenging listening situations. Speech in noise scores just 1.0/5, falling 0.48 points below the category average—a meaningful weakness for those who frequently encounter noisy environments. Own-voice comfort is mixed at 2.5/5, essentially matching the category average. At this price point, shoppers should note that several competitors deliver stronger overall performance. The Jabra Enhance Select 500 scores 4.16/5, while the Lucid Tala and Audicus Omni 2 both exceed 4.5/5. For those prioritizing value, devices like the Sony CRE-C20 offer similar sound performance at lower prices. The Select 50R is best suited for users who primarily need help hearing in quieter settings and value Jabra's ecosystem and reliable feedback control.

The ReSound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In our lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #29 of 39 prescription hearing aids tested. This device shows a mixed performance profile. Its standout strength is own-voice comfort, scoring 3.4/5—a solid result that sits 0.70 points above the category average. Speech clarity in quiet environments also performs at category average with a score of 3.4/5. Feedback handling is strong in absolute terms at 4.2/5, though this falls 0.52 points below the category average, reflecting the high bar set by competing prescription devices. The Vivia 9's most notable weakness is speech understanding in noisy environments, where it scored just 1.1/5—a low result that trails the category average by 0.96 points. Music streaming performance is mixed at 2.6/5, sitting slightly below average. These limitations are worth considering given the premium price positioning. For listeners who prioritize comfortable own-voice perception and primarily encounter quieter listening situations, the Vivia 9 may be suitable. However, those frequently in challenging noise environments should note that several alternatives in this price range—including the Phonak Sphere Infinio and Oticon Intent—deliver stronger overall performance in our testing. Budget-conscious shoppers may also find comparable sound quality at lower price points with options like the Jabra Enhance Pro 20 at Costco.